Post job

Prevail Therapeutics's revenue is $74.3 million.

What is Prevail Therapeutics's revenue?

Prevail Therapeutics's annual revenue is $74.3M. Zippia's data science team found the following key financial metrics about Prevail Therapeutics after extensive research and analysis.
  • Prevail Therapeutics has 66 employees, and the revenue per employee ratio is $1,125,758.
  • Prevail Therapeutics peak revenue was $74.3M in 2024.

On this page

Peak revenue
$74.3M (2024)
Company peak revenue
Revenue / employee
$1.1M
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$74.3M (2024)
Company peak revenue
Revenue / employee
$1.1M
Company revenue / employee

Prevail Therapeutics financing

Prevail Therapeutics received early financing of $4.0M on 2017-08-01.

SeriesRound sizeDate
Seed$4M08/2017
Series A$75M03/2018
Series B$50M03/2019

Prevail Therapeutics investors

InvestorsSecurity type
EcoR1 Capital, LLCSeries A
Omega FundsSeries A
Adage Capital ManagementSeries A
Biotechnology Value FundSeries A
OrbiMed AdvisorsSeries A
RA Capital ManagementSeries A
Boxer CapitalSeries A
Alexandria Venture InvestmentsSeries A
Pontifax LtdSeries A
EcoR1 Capital, LLCSeries B
Omega FundsSeries B
Adage Capital ManagementSeries B
Biotechnology Value FundSeries B
OrbiMed AdvisorsSeries B
AbbVie Biotech Ventures IncSeries B
RA Capital ManagementSeries B
Boxer CapitalSeries B
Alexandria Venture InvestmentsSeries B
Surveyor CapitalSeries B
Pontifax LtdSeries B

Prevail Therapeutics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Prevail Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Prevail Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Prevail Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Prevail Therapeutics. The data presented on this page does not represent the view of Prevail Therapeutics and its employees or that of Zippia.

Prevail Therapeutics may also be known as or be related to Prevail Therapeutics Inc, Prevail Therapeutics, Inc.,, PREVAIL THERAPEUTICS INC., Prevail Therapeutics and Prevail Therapeutics Inc.